Aurora Cannabis Achieves Record Positive EBITDA in Q2 2024
Aurora Cannabis has announced its fiscal Q2 2024 results, reporting a record positive adjusted EBITDA of $3.4 million. The company saw a 30% year-over-year increase in net revenue, reaching $63.4 million, with strong growth of 42% in global medical cannabis. Aurora also highlighted its net cash position of over $200 million and reaffirmed its target of achieving positive free cash flow in calendar year 2024. The company plans to capture $40 million in annualized cost efficiencies during fiscal 2024 and expects to repay the remaining balance of its convertible senior notes in February 2024.